InvestorsHub Logo
icon url

philsdaddy

12/14/12 11:09 AM

#14241 RE: petemantx #14239

According to the Clinical Trials site, the first cohort patients were to receive three weekly one-hour infusions, followed by one off week. I assume this is the off-week. I didn't see anything on that site about the double dosing of either cohort--must be on another detailed report--does anyone else have other links?http://clinicaltrials.gov/show/NCT01664000

Lee
icon url

BonelessCat

12/14/12 11:18 AM

#14250 RE: petemantx #14239

Read it again:
In addition to patients in the first cohort now receiving their second cycle of dosing, the Institutional Review Board (“IRB”) and Safety Committee have approved escalated dosing levels for the second cohort.  The Company has been advised that the second cohort will begin dosing during the week beginning December 16.
The first cohort is "now receiving", the second cohort "will begin" next week. Like I said, I don't know how far to interpret this. If the two cohorts will dose together, it would have been stated in that way IMO.